AI Vendor Risk in Clinical Research Starts With the Trial Data Flow
FDA guidance expects sponsors to document electronic systems, data flows, access controls, contracts, audit trails, and service-provider responsibilities across a clinical investigation. An AI vendor that receives protocol text or participant records becomes part of that evidence chain. This article maps vendor review onto each authenticated model request.